Page last updated: 2024-11-02

pd 98059 and Osteolysis

pd 98059 has been researched along with Osteolysis in 2 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Osteolysis: Dissolution of bone that particularly involves the removal or loss of calcium.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seo, SW1
Lee, D1
Minematsu, H1
Kim, AD1
Shin, M1
Cho, SK1
Kim, DW1
Yang, J1
Lee, FY1
Lentzsch, S1
Gries, M1
Janz, M1
Bargou, R1
Dörken, B1
Mapara, MY1

Other Studies

2 other studies available for pd 98059 and Osteolysis

ArticleYear
Targeting extracellular signal-regulated kinase (ERK) signaling has therapeutic implications for inflammatory osteolysis.
    Bone, 2010, Volume: 46, Issue:3

    Topics: Animals; Cell Line; Drug Delivery Systems; Flavonoids; Inflammation Mediators; Male; MAP Kinase Sign

2010
Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells.
    Blood, 2003, May-01, Volume: 101, Issue:9

    Topics: Androstadienes; Cell Division; Cell Survival; Chemokine CCL3; Chemokine CCL4; Cytokines; Enzyme Acti

2003